Document is current
Any future updates will be listed below
-
Authors
Liu, Fei
Li, Panli
Xu, Junyan
Zhang, Jianping
Xu, Xiaoping
Chen, Zhihao
Qiao, Ying
Liang, Yun
Chen, Jie
Song, Shaoli https://orcid.org/0000-0003-2544-7522
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05459844 at ClinicalTrials.govDocuments that mention this clinical trial
Radiation exposure and protection advice after [177Lu]Lu-DOTA-TATE therapy in China
https://doi.org/10.1186/s13550-024-01185-4
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82102097, U23A20465)
Science and Technology Commission of Shanghai Municipality (23DZ2291400, 23TS1400800)
- License Information
-
More Information
Article History
Received: 8 August 2024
Accepted: 20 November 2024
First Online: 28 November 2024
Declarations
:
: The study was approved by the Ethics Committee of FUSCC (Approval No. 2210262-2). All patients provided written informed consent to participate in the study. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Written informed consent for publication was obtained from all study participant.
: The authors declare that they have no competing interests.
